Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Liver transplantation for non-alcoholic fatty liver disease: indications and post-transplant management
Sara Battistella, Francesca D’Arcangelo, Marco Grasso, et al.
Clinical and Molecular Hepatology (2022) Vol. 29, Iss. Suppl, pp. S286-S301
Open Access | Times Cited: 34

Showing 1-25 of 34 citing articles:

Exploring the Multifaceted Landscape of MASLD: A Comprehensive Synthesis of Recent Studies, from Pathophysiology to Organoids and Beyond
Allison Soto, Colby Spongberg, Alessandro Martinino, et al.
Biomedicines (2024) Vol. 12, Iss. 2, pp. 397-397
Open Access | Times Cited: 22
Evaluation and Management of Nutritional Consequences of Chronic Liver Diseases
Silvia Espina, Diego Casas Deza, Vanesa Bernal Monterde, et al.
Nutrients (2023) Vol. 15, Iss. 15, pp. 3487-3487
Open Access | Times Cited: 22
Preclinical Promise and Clinical Challenges for Innovative Therapies Targeting Liver Fibrogenesis
Tamer A. Addissouky, Majeed M. A. Ali, Ibrahim El Tantawy El Sayed, et al.
Archives of Gastroenterology Research (2023) Vol. 4, Iss. 1, pp. 14-23
Open Access | Times Cited: 21
New Developments and Challenges in Liver Transplantation
Amjad Khalil, Alberto Quaglia, Pierre Gélat, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 17, pp. 5586-5586
Open Access | Times Cited: 17
Liver fibrosis and MAFLD: the exploration of multi-drug combination therapy strategies
Qingfu Dong, Haolin Bao, Jiangang Wang, et al.
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 16
Metabolic dysfunction-associated steatotic liver disease: A silent pandemic
Arghya Samanta, Moinak Sen Sarma
World Journal of Hepatology (2024) Vol. 16, Iss. 4, pp. 511-516
Open Access | Times Cited: 5
Macronutrient modulation in metabolic dysfunction-associated steatotic liver disease – the molecular role of fatty acids versus sugars in human metabolism and disease progression
Sinéad M. Mullin, A. K. Kelly, Méabh B. Ní Chathail, et al.
Advances in Nutrition (2025), pp. 100375-100375
Open Access
Metabolic Dysfunction-Associated Steatotic Liver Disease: Pathogenetic Links to Cardiovascular Risk
Vlad Ionescu, Gina Gheorghe, Nicolae Bacalbaşa, et al.
Biomolecules (2025) Vol. 15, Iss. 2, pp. 163-163
Open Access
Metabolic dysfunction-associated steatotic liver disease correlates with higher lower graft survival in liver transplant recipients with hepatocellular carcinoma
Marwan Alsaqa, Leandro Sierra, Ana Marenco-Flores, et al.
European Journal of Gastroenterology & Hepatology (2025)
Closed Access
Cardiac Remodeling and Arrhythmic Burden in Pre-Transplant Cirrhotic Patients: Pathophysiological Mechanisms and Management Strategies
Charilila-Loukia Ververeli, Yannis Dimitroglou, Στέργιος Σουλαϊδόπουλος, et al.
Biomedicines (2025) Vol. 13, Iss. 4, pp. 812-812
Open Access
MASLD or MAFLD: fatty liver by any name will pose the same challenge
Anil C. Anand, Dibyalochan Praharaj
Metabolism and Target Organ Damage (2025) Vol. 5, Iss. 2
Open Access
Clinical and Economic Burden of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) in a Spanish Mediterranean Region: A Population-Based Study
J.A. Carnicero, Inmaculada Saurí, Josep Redón, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 7, pp. 2441-2441
Open Access
Risk Factors Related to the Development of Nonalcoholic Fatty Liver: A Systematic Review
Omaira Valencia, M. Mateus, Esteban Vanegas Duarte, et al.
Canadian Journal of Gastroenterology and Hepatology (2025) Vol. 2025, Iss. 1
Open Access
SAFETY, EFFICACY AND OUTCOMES OF INVASIVE CORONARY ANGIOGRAPHY IN LIVER TRANSPLANT CANDIDATES
Carme Ginard, Giulia Pagano, Salvatore Brugaletta, et al.
JHEP Reports (2025), pp. 101428-101428
Open Access
Plasma ALS and Gal-3BP differentiate early from advanced liver fibrosis in MASLD patients
David Pérez Compte, Lucas Etourneau, Anne-Marie Hesse, et al.
Biomarker Research (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 3
Recent trends and new developments in liver transplantation
Yasuhiko Sugawara, Taizo Hibi
BioScience Trends (2024) Vol. 18, Iss. 3, pp. 206-211
Open Access | Times Cited: 3
Metabolic bariatric surgery, alcohol misuse and liver cirrhosis: a narrative review
Matthew L. Basa, S. Danielle, David Mitchell, et al.
Metabolism and Target Organ Damage (2024) Vol. 4, Iss. 3
Open Access | Times Cited: 3
Weight Loss After Sleeve Gastrectomy According to Metabolic Dysfunction-Associated Steatotic Liver Disease Stage in Patients with Obesity: A Liver Biopsy-Based Prospective Study
José Ignacio Martínez‐Montoro, Isabel Arranz‐Salas, Carolina Gutiérrez‐Repiso, et al.
Nutrients (2024) Vol. 16, Iss. 22, pp. 3857-3857
Open Access | Times Cited: 2
Outcomes in elderly patients undergoing hepatic resection compared to liver transplant for hepatocellular carcinoma
Sameer Khan, Fasih Ali Ahmed, Muhammad Saad Hafeez, et al.
Journal of Surgical Oncology (2023) Vol. 128, Iss. 8, pp. 1320-1328
Open Access | Times Cited: 4
Diabetes and Metabolic Disorders: Their Impact on Cardiovascular Events in Liver Transplant Patients
Simone Di Cola, Giulia Cusi, Lucia Lapenna, et al.
Canadian Journal of Gastroenterology and Hepatology (2023) Vol. 2023, pp. 1-9
Open Access | Times Cited: 3
How best to combine liver transplantation and bariatric surgery?—Results from a global, web‐based survey
Jeannette Widmer, Janina Eden, Fariba Abbassi, et al.
Liver International (2023) Vol. 44, Iss. 2, pp. 566-576
Closed Access | Times Cited: 3
Exploring the effects of epigallocatechin gallate on lipid metabolism in the rat steatotic liver during normothermic machine perfusion: Insights from lipidomics and RNA sequencing
Shuxuan Li, Zhi Yao, Wentao Mu, et al.
European Journal of Pharmacology (2023) Vol. 964, pp. 176300-176300
Closed Access | Times Cited: 3
Community Series - Liver Fibrosis and MAFLD: from Molecular Aspects to Novel Pharmacological Strategies, Volume II

Frontiers research topics (2024)
Open Access
Cardiac abnormalities pre- and post-liver transplantation for metabolic dysfunction-associated steatohepatitis – Evidence and special considerations
Steven M. Elzein, Elizabeth W. Brombosz, Sudha Kodali
Journal of Liver Transplantation (2024) Vol. 15, pp. 100228-100228
Open Access
Serum Creatinine as an Independent Predictor of Moderate to Severe Fibrosis in Chinese American Non-obese Metabolic Dysfunction-Associated Steatotic Liver Disease
Michael Sun, Vincent J.H. Yao, Aivi A. Rahman, et al.
Cureus (2024)
Open Access
Page 1 - Next Page

Scroll to top